J.j. David Ho

J.J. David Ho has a diverse work experience in the field of scientific research. J.J. David is currently working as a Principal Scientist at Kestrel Therapeutics since January 2024. Prior to this, they held the position of Senior Scientist II at Ananke Therapeutics from October 2022 to January 2024.

Before joining Ananke Therapeutics, J.J. David Ho served as a Senior Scientist and Scientist at Hexagon Bio from April 2021 to September 2022 and from January 2022 to December 2021, respectively.

J.J. David'sprevious experiences also include working at the University of Miami, Miller School of Medicine. J.J. David held the role of Associate Scientist at the Sylvester Comprehensive Cancer Center from April 2018 to April 2021. Before that, they worked as an Assistant Scientist from April 2017 to March 2018 and as a Postdoctoral Fellow from August 2014 to April 2017.

J.J. David Ho started their career as a Post-Doctoral Fellow at the University of Ottawa in the Department of Cellular and Molecular Medicine, Faculty of Medicine. J.J. David worked there from February 2014 to July 2014, focusing on the study of oxygen, hypoxia, translatome remodeling, protein synthesis machinery, and cancer.

Overall, J.J. David Ho has demonstrated expertise in various aspects of scientific research, including tumor microenvironment, drug-induced translational remodeling, and cancer-related studies.

J.J. David Ho completed an Honors Bachelor of Science (Hon. BSc) degree in Molecular Biology from the University of Toronto between 2003 and 2006. Following this, they pursued a Doctor of Philosophy (Ph.D.) degree in Cell/Cellular and Molecular Biology from the same university from 2007 to 2013.